 The purpose of this study is to demonstrate that the intestinal absorption of calcium from a novel calcium carbonate-vitamin D3 chewable tablet formulation calcium 500 milligrams mg and vitamin D3 1000 International Units IU increases the amount of calcium excreted in urine and decreases parathyroid hormone PTH in serum as compared with Baseline. 